TORONTO, June 16, 2026 (GLOBE NEWSWIRE) — PsyCan, the trade association representing Canada’s legally operating medical psychedelics sector, welcomes the introduction of Bill C-286, a private member’s ...
Neil Batlivala has spent seven years building a healthcare company that most of the tech industry has never heard of and that serves a patient population most of Silicon Valley ignores. But last month ...
On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) announced “a new pathway designed to expedite access to certain FDA-designated Class II ...
The Trump administration is testing out a new 10-year program for value-based chronic condition management that leans heavily on technology and artificial intelligence to scale to large populations of ...
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) ("PharmAla" or the "Company"), a global leader in the research, development and manufacturing of ...
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...
REMOVING BARRIERS TO PSYCHEDELIC DRUGS AS POTENTIAL TREATMENT FOR SERIOUS MENTAL ILLNESS: Today, President Donald J. Trump signed an Executive Order that will accelerate access to treatments for ...
LONDON, April 14 (Reuters) - Commodity trader and miner Glencore (GLEN.L), opens new tab has taken back ownership of Access World, the global logistics firm said on Tuesday. Glencore's ownership is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results